Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 138,900 shares at $19.82 ($2.8M) on 2021-11-11, disclosed to the SEC on 2021-11-12.
Open-market sale of $2.8M EWTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.94 | 16,864 | $336K | 12.2% |
| 2 | $19.94 | 16,864 | $336K | 12.2% |
| 3 | $20.30 | 12,712 | $258K | 9.3% |
| 4 | $20.30 | 12,712 | $258K | 9.3% |
| 5 | $19.70 | 11,746 | $231K | 8.4% |
| 6 | $19.70 | 11,746 |
| $231K |
| 8.4% |
| 7 | $20.21 | 580 | $12K | 0.4% |
| 8 | $19.82 | 15,595 | $309K | 11.2% |
| 9 | $19.82 | 15,595 | $309K | 11.2% |
| 10 | $20.43 | 3,681 | $75K | 2.7% |
| 11 | $20.43 | 3,681 | $75K | 2.7% |
| 12 | $19.51 | 8,562 | $167K | 6.0% |
| 13 | $19.51 | 8,562 | $167K | 6.0% |
| Total | $19.91 avg | 138,900 | $2.8M | 100% |
| Filing → |
| EWTX | SELL | 2025-11-13 | $2.1M | — | Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |